Abstract: Drug risk management runs through the entire life cycle of the drug.The risk and benefit evaluation is the core in pre and post-marketing evaluation. Establishment of in-depth pharmacovigilance actively is essential to enforce the drug regulation and safe/effective use of medication.The International Society of Pharmacovigilance(ISoP) is an independent non-profit international academic authority. It is an open and impartial international academic platform for experience and knowledge sharing， which aims to advocate international pharmacovigilance scientifically， and promote the development of pharmacovigilance and risk management.This article introduces the ISoP′s establishment， development， objectives， tasks and the situation of the academic communication. ISoP has set up a professional platform for the sharing of experience and knowledge for people who engages in drug safety and pharmacovigilance in all countries. It opens a window to extend our understanding to the development of the international pharmacovigilance and risk management strategy. It merits great attention and active participation for Chinese professionals， such as researchers， healthcare professionals， industry， academic and the government regulators in the field of pharmacovigilance， drug safety and drug evaluation.